Key facts
- This page summarizes Karen Wendel's Form 4 filing for Beneficient (BENF).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 21 Oct 2026, 16:15.
Karen Wendel - 30 Sep 2026 Form 4 Insider Report for Beneficient (BENF)
- Reporting relationship
- Director
- Issuer ticker
- BENF
- Reported as of
- 30 Sep 2026
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 21 Oct 2026, 16:15:14 UTC
- Prior SEC filing
- 22 Sep 2026
- Source filing
- View source filing
- Reporting owner signature
- By: /s/ David B. Rost, Attorney-in-fact for Karen Wendel
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Filing notes and source
Key filing fact
Karen Wendel filed Form 4 for Beneficient (BENF) on 21 Oct 2026.
Change
- Previous filing in this sequence was filed on 22 Sep 2026.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001744198
Primary reporting owner
Wendel Karen
- Relationship
- Director
- Address
- 325 N. SAINT PAUL STREET, SUITE 4850, DALLAS
- Signature
- By: /s/ David B. Rost, Attorney-in-fact for Karen Wendel
- Signature date
- 21 Oct 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
BENF
transaction
Class A Common Stock
Award
- Transaction value
- Shares
- +25,689
- Change %
- +25%
- Price
- $0.000000*
- Shares after
- 128,579
- Date
- 30 Sep 2026
- Ownership
- Direct
- Footnotes
- F1, F2, F3, F4
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 4 footnotes
Footnote F1
Includes 25,689 shares of Class A common stock, par value $0.001 ("Class A common stock"), of Beneficient (the "Issuer") issuable upon the settlement of an award of 25,689 restricted stock units ("RSUs") granted pursuant to the Beneficient 2023 Equity Incentive Plan ("2023 Equity Incentive Plan") to Karen Wendel (the "Reporting Person") on September 30, 2026. Such award of RSUs to the Reporting Person fully vested on the date of grant.
Footnote F2
Includes 32,960 shares of Class A common stock issuable upon the settlement of an award of 32,960 RSUs granted pursuant to the 2023 Equity Incentive Plan to the Reporting Person on September 18, 2026. Such award of RSUs to the Reporting Person fully vested on the date of grant.
Footnote F3
Includes 25,914 shares of Class A common stock issuable upon the settlement of an award of 25,914 RSUs granted pursuant to the 2023 Equity Incentive Plan to the Reporting Person on November 21, 2024. Such award of RSUs to the Reporting Person vested in four equal installments on the last day of each calendar quarter over a one-year period from the date of grant.
Footnote F4
Includes 44,016 shares of Class A common stock issuable upon the settlement of an award of 44,016 RSUs granted to the Reporting Person on September 18, 2026 pursuant to the 2023 Equity Incentive Plan. The RSUs were granted in satisfaction of the Reporting Person's prior service compensation for the period from November 22, 2025 through March 31, 2026. Such award of RSUs to the Reporting Person fully vested on the date of grant.